Bruce S. Colwill's most recent trade in InMed Pharmaceuticals Inc was a trade of 5,000 Common Stock done at an average price of $1.1 . Disclosure was reported to the exchange on Jan. 24, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| InMed Pharmaceuticals Inc | Bruce S. Colwill | CFO | Purchase of securities on an exchange or from another person at price $ 1.09 per share. | 24 Jan 2022 | 5,000 | 11,515 | - | 1.1 | 5,439 | Common Stock |
| InMed Pharmaceuticals Inc | Bruce S. Colwill | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Oct 2021 | 60,000 | 150,303 | - | - | Employee Stock Option (Right to Buy) | |
| InMed Pharmaceuticals Inc | Bruce S. Colwill | CFO | Purchase of securities on an exchange or from another person at price $ 1.77 per share. | 28 Sep 2021 | 5,000 | 6,515 | - | 1.8 | 8,840 | Common Stock |
| InMed Pharmaceuticals Inc | Bruce S. Colwill | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Dec 2020 | 60,000 | 60,000 | - | - | Employee Stock Option (Right to Buy) |